Go Pro

Scotiabank Issues Pessimistic Forecast for Kinaxis Earnings

Kinaxis logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Scotiabank lowered its FY2026 EPS forecast for Kinaxis to $2.46 from $2.47, well below the broader consensus estimate of $4.25; it projects FY2027 EPS of $3.33.
  • Despite the cautious forecast, analysts remain broadly positive: Kinaxis has a consensus “Buy” rating and a consensus price target of C$203.12, with several firms recently raising their targets.
  • Kinaxis reported quarterly revenue of C$230.64 million and EPS of C$1.08, while insiders have sold 25,664 shares worth approximately C$4.3 million over the past three months.
  • Five stocks we like better than Kinaxis.

Kinaxis Inc. (TSE:KXS - Free Report) - Scotiabank decreased their FY2026 EPS estimates for shares of Kinaxis in a research note issued to investors on Wednesday, August 19th. Scotiabank analyst K. Krishnaratne now expects that the company will post earnings per share of $2.46 for the year, down from their previous estimate of $2.47. The consensus estimate for Kinaxis' current full-year earnings is $4.25 per share. Scotiabank also issued estimates for Kinaxis' FY2027 earnings at $3.33 EPS.

Other equities analysts have also recently issued research reports about the company. Royal Bank Of Canada boosted their price target on Kinaxis from C$200.00 to C$210.00 and gave the stock an "outperform" rating in a report on Friday, May 8th. National Bank Financial raised their price objective on Kinaxis from C$200.00 to C$210.00 and gave the company an "outperform" rating in a research note on Friday, August 7th. Canadian Imperial Bank of Commerce lifted their target price on Kinaxis from C$173.00 to C$205.00 in a research report on Friday, June 5th. BMO Capital Markets boosted their target price on Kinaxis from C$195.00 to C$200.00 and gave the stock an "outperform" rating in a research note on Friday, August 7th. Finally, Stifel Nicolaus dropped their target price on shares of Kinaxis from C$245.00 to C$200.00 and set a "buy" rating for the company in a report on Wednesday, May 6th. Seven analysts have rated the stock with a Buy rating, According to MarketBeat.com, Kinaxis currently has a consensus rating of "Buy" and a consensus price target of C$203.12.

Read Our Latest Stock Analysis on Kinaxis

Kinaxis Stock Performance

Shares of KXS stock opened at C$179.75 on Monday. The stock's fifty day moving average price is C$159.68 and its two-hundred day moving average price is C$147.09. The company has a market cap of C$4.89 billion, a PE ratio of 58.74, a P/E/G ratio of 3.60 and a beta of 0.76. Kinaxis has a fifty-two week low of C$117.22 and a fifty-two week high of C$196.63. The company has a debt-to-equity ratio of 11.14, a quick ratio of 2.29 and a current ratio of 1.88.

Kinaxis (TSE:KXS - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported C$1.08 earnings per share (EPS) for the quarter. Kinaxis had a net margin of 14.40% and a return on equity of 20.88%. The business had revenue of C$230.64 million for the quarter.

Insider Transactions at Kinaxis

In other Kinaxis news, Director Robert G. Courteau sold 5,010 shares of the business's stock in a transaction on Friday, May 29th. The shares were sold at an average price of C$151.39, for a total transaction of C$758,463.90. Following the sale, the director owned 32,945 shares of the company's stock, valued at approximately C$4,987,543.55. The trade was a 13.20% decrease in their ownership of the stock. Also, insider Andrew William Robert Bell sold 703 shares of the company's stock in a transaction on Friday, August 14th. The stock was sold at an average price of C$171.46, for a total transaction of C$120,536.38. Following the transaction, the insider owned 1,455 shares of the company's stock, valued at C$249,474.30. This trade represents a 32.58% decrease in their ownership of the stock. Over the last three months, insiders have sold 25,664 shares of company stock valued at $4,300,572. Corporate insiders own 1.20% of the company's stock.

Kinaxis Company Profile

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain - from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines